SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-076713
Filing Date
2015-11-06
Accepted
2015-11-06 16:32:59
Documents
8
Period of Report
2015-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-22566_18k.htm 8-K 31193
2 EX-1.1 a15-22566_1ex1d1.htm EX-1.1 291368
3 EX-5.1 a15-22566_1ex5d1.htm EX-5.1 20954
4 EX-99.1 a15-22566_1ex99d1.htm EX-99.1 12545
5 EX-99.2 a15-22566_1ex99d2.htm EX-99.2 13106
6 GRAPHIC g225661mmi001.jpg GRAPHIC 3953
7 GRAPHIC g225661kii001.jpg GRAPHIC 2500
8 GRAPHIC g225661moi001.jpg GRAPHIC 3953
  Complete submission text file 0001104659-15-076713.txt   385167
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 151212387
SIC: 2834 Pharmaceutical Preparations